 | • レポートコード：GIR-105X03148 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、がん性疼痛のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。がん性疼痛の種類別市場規模（オピオイド、非ステロイド性抗炎症薬、その他）、用途別市場規模（放射線療法、化学療法、ホルモン療法、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・がん性疼痛の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：BioDelivery Science、ProStrakan Group、Teva pharmaceuticals、Eli-Lilly、Grunenthal Group、GW Pharmaceuticals、Johnson＆Johnson、Meda Pharmaceuticals、Orexo、Sanofi、WEX Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：オピオイド、非ステロイド性抗炎症薬、その他 ・用途別分析2016年-2026年：放射線療法、化学療法、ホルモン療法、その他 ・がん性疼痛の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・がん性疼痛のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・がん性疼痛のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・がん性疼痛の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・がん性疼痛の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Cancer Pain market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Cancer Pain size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Cancer Pain market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Cancer Pain market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Opioids
Non-Steroidal Anti-Inflammatory Drugs
Others
Market segment by Application can be divided into
Radiotherapy
Chemotherapy
Hormone Therapy
Others
The key market players for global Cancer Pain market are listed below:
BioDelivery Science
ProStrakan Group
Teva pharmaceuticals
Eli-Lilly
Grunenthal Group
GW Pharmaceuticals
Johnson＆Johnson
Meda Pharmaceuticals
Orexo
Sanofi
WEX Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Cancer Pain product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cancer Pain, with price, sales, revenue and global market share of Cancer Pain from 2019 to 2021.
Chapter 3, the Cancer Pain competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Pain breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Cancer Pain market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Cancer Pain sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Cancer Pain Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cancer Pain Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Opioids
1.2.3 Non-Steroidal Anti-Inflammatory Drugs
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Cancer Pain Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Radiotherapy
1.3.3 Chemotherapy
1.3.4 Hormone Therapy
1.3.5 Others
1.4 Global Cancer Pain Market Size & Forecast
1.4.1 Global Cancer Pain Sales in Value (2016-2026))
1.4.2 Global Cancer Pain Sales in Volume (2016-2026)
1.4.3 Global Cancer Pain Price by Type (2016-2026) & (USD/Unit)
1.5 Global Cancer Pain Production Capacity Analysis
1.5.1 Global Cancer Pain Total Production Capacity (2016-2026)
1.5.2 Global Cancer Pain Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Cancer Pain Market Drivers
1.6.2 Cancer Pain Market Restraints
1.6.3 Cancer Pain Trends Analysis
2 Manufacturers Profiles
2.1 BioDelivery Science
2.1.1 BioDelivery Science Details
2.1.2 BioDelivery Science Major Business
2.1.3 BioDelivery Science Cancer Pain Product and Services
2.1.4 BioDelivery Science Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 ProStrakan Group
2.2.1 ProStrakan Group Details
2.2.2 ProStrakan Group Major Business
2.2.3 ProStrakan Group Cancer Pain Product and Services
2.2.4 ProStrakan Group Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Teva pharmaceuticals
2.3.1 Teva pharmaceuticals Details
2.3.2 Teva pharmaceuticals Major Business
2.3.3 Teva pharmaceuticals Cancer Pain Product and Services
2.3.4 Teva pharmaceuticals Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Eli-Lilly
2.4.1 Eli-Lilly Details
2.4.2 Eli-Lilly Major Business
2.4.3 Eli-Lilly Cancer Pain Product and Services
2.4.4 Eli-Lilly Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Grunenthal Group
2.5.1 Grunenthal Group Details
2.5.2 Grunenthal Group Major Business
2.5.3 Grunenthal Group Cancer Pain Product and Services
2.5.4 Grunenthal Group Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 GW Pharmaceuticals
2.6.1 GW Pharmaceuticals Details
2.6.2 GW Pharmaceuticals Major Business
2.6.3 GW Pharmaceuticals Cancer Pain Product and Services
2.6.4 GW Pharmaceuticals Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Johnson＆Johnson
2.7.1 Johnson＆Johnson Details
2.7.2 Johnson＆Johnson Major Business
2.7.3 Johnson＆Johnson Cancer Pain Product and Services
2.7.4 Johnson＆Johnson Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Meda Pharmaceuticals
2.8.1 Meda Pharmaceuticals Details
2.8.2 Meda Pharmaceuticals Major Business
2.8.3 Meda Pharmaceuticals Cancer Pain Product and Services
2.8.4 Meda Pharmaceuticals Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Orexo
2.9.1 Orexo Details
2.9.2 Orexo Major Business
2.9.3 Orexo Cancer Pain Product and Services
2.9.4 Orexo Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Sanofi
2.10.1 Sanofi Details
2.10.2 Sanofi Major Business
2.10.3 Sanofi Cancer Pain Product and Services
2.10.4 Sanofi Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 WEX Pharmaceuticals
2.11.1 WEX Pharmaceuticals Details
2.11.2 WEX Pharmaceuticals Major Business
2.11.3 WEX Pharmaceuticals Cancer Pain Product and Services
2.11.4 WEX Pharmaceuticals Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Cancer Pain Sales by Manufacturer
3.1 Global Cancer Pain Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Cancer Pain Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Cancer Pain
3.4 Market Concentration Rate
3.4.1 Top 3 Cancer Pain Manufacturer Market Share
3.4.2 Top 6 Cancer Pain Manufacturer Market Share
3.5 Global Cancer Pain Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Cancer Pain Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Cancer Pain Market Size by Region
4.1.1 Global Cancer Pain Sales in Volume by Region (2016-2026)
4.1.2 Global Cancer Pain Revenue by Region (2016-2026)
4.2 North America Cancer Pain Revenue (2016-2026)
4.3 Europe Cancer Pain Revenue (2016-2026)
4.4 Asia-Pacific Cancer Pain Revenue (2016-2026)
4.5 South America Cancer Pain Revenue (2016-2026)
4.6 Middle East and Africa Cancer Pain Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Cancer Pain Sales in Volume by Type (2016-2026)
5.2 Global Cancer Pain Revenue by Type (2016-2026)
5.3 Global Cancer Pain Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Cancer Pain Sales in Volume by Application (2016-2026)
6.2 Global Cancer Pain Revenue by Application (2016-2026)
6.3 Global Cancer Pain Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Cancer Pain Sales by Type (2016-2026)
7.2 North America Cancer Pain Sales by Application (2016-2026)
7.3 North America Cancer Pain Market Size by Country
7.3.1 North America Cancer Pain Sales in Volume by Country (2016-2026)
7.3.2 North America Cancer Pain Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Cancer Pain Sales by Type (2016-2026)
8.2 Europe Cancer Pain Sales by Application (2016-2026)
8.3 Europe Cancer Pain Market Size by Country
8.3.1 Europe Cancer Pain Sales in Volume by Country (2016-2026)
8.3.2 Europe Cancer Pain Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Cancer Pain Sales by Type (2016-2026)
9.2 Asia-Pacific Cancer Pain Sales by Application (2016-2026)
9.3 Asia-Pacific Cancer Pain Market Size by Region
9.3.1 Asia-Pacific Cancer Pain Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Cancer Pain Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Cancer Pain Sales by Type (2016-2026)
10.2 South America Cancer Pain Sales by Application (2016-2026)
10.3 South America Cancer Pain Market Size by Country
10.3.1 South America Cancer Pain Sales in Volume by Country (2016-2026)
10.3.2 South America Cancer Pain Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Cancer Pain Sales by Type (2016-2026)
11.2 Middle East & Africa Cancer Pain Sales by Application (2016-2026)
11.3 Middle East & Africa Cancer Pain Market Size by Country
11.3.1 Middle East & Africa Cancer Pain Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Cancer Pain Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Cancer Pain Typical Distributors
12.3 Cancer Pain Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Cancer Pain Revenue by Type, (USD Million), 2021-2026
Table 2. Global Cancer Pain Revenue by Application, (USD Million), 2021-2026
Table 3. BioDelivery Science Basic Information, Manufacturing Base and Competitors
Table 4. BioDelivery Science Major Business
Table 5. BioDelivery Science Cancer Pain Product and Services
Table 6. BioDelivery Science Cancer Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. ProStrakan Group Basic Information, Manufacturing Base and Competitors
Table 8. ProStrakan Group Major Business
Table 9. ProStrakan Group Cancer Pain Product and Services
Table 10. ProStrakan Group Cancer Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Teva pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Teva pharmaceuticals Major Business
Table 13. Teva pharmaceuticals Cancer Pain Product and Services
Table 14. Teva pharmaceuticals Cancer Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Eli-Lilly Basic Information, Manufacturing Base and Competitors
Table 16. Eli-Lilly Major Business
Table 17. Eli-Lilly Cancer Pain Product and Services
Table 18. Eli-Lilly Cancer Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Grunenthal Group Basic Information, Manufacturing Base and Competitors
Table 20. Grunenthal Group Major Business
Table 21. Grunenthal Group Cancer Pain Product and Services
Table 22. Grunenthal Group Cancer Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. GW Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. GW Pharmaceuticals Major Business
Table 25. GW Pharmaceuticals Cancer Pain Product and Services
Table 26. GW Pharmaceuticals Cancer Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Johnson＆Johnson Basic Information, Manufacturing Base and Competitors
Table 28. Johnson＆Johnson Major Business
Table 29. Johnson＆Johnson Cancer Pain Product and Services
Table 30. Johnson＆Johnson Cancer Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Meda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Meda Pharmaceuticals Major Business
Table 33. Meda Pharmaceuticals Cancer Pain Product and Services
Table 34. Meda Pharmaceuticals Cancer Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Orexo Basic Information, Manufacturing Base and Competitors
Table 36. Orexo Major Business
Table 37. Orexo Cancer Pain Product and Services
Table 38. Orexo Cancer Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Sanofi Basic Information, Manufacturing Base and Competitors
Table 40. Sanofi Major Business
Table 41. Sanofi Cancer Pain Product and Services
Table 42. Sanofi Cancer Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. WEX Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. WEX Pharmaceuticals Major Business
Table 45. WEX Pharmaceuticals Cancer Pain Product and Services
Table 46. WEX Pharmaceuticals Cancer Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Cancer Pain Sales by Manufacturer (2019-2021e) & (K Units)
Table 48. Global Cancer Pain Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Cancer Pain, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Cancer Pain Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Cancer Pain Production Site of Key Manufacturer
Table 52. Cancer Pain New Entrant and Capacity Expansion Plans
Table 53. Cancer Pain Mergers & Acquisitions in the Past Five Years
Table 54. Global Cancer Pain Sales by Region (2016-2021e) & (K Units)
Table 55. Global Cancer Pain Sales by Region (2021-2026) & (K Units)
Table 56. Global Cancer Pain Revenue by Region (2016-2021e) & (USD Million)
Table 57. Global Cancer Pain Revenue by Region (2021-2026) & (USD Million)
Table 58. Global Cancer Pain Sales by Type (2016-2021e) & (K Units)
Table 59. Global Cancer Pain Sales by Type (2021-2026) & (K Units)
Table 60. Global Cancer Pain Revenue by Type (2016-2021e) & (USD Million)
Table 61. Global Cancer Pain Revenue by Type (2021-2026) & (USD Million)
Table 62. Global Cancer Pain Price by Type (2016-2021e) & (USD/Unit)
Table 63. Global Cancer Pain Price by Type (2021-2026) & (USD/Unit)
Table 64. Global Cancer Pain Sales by Application (2016-2021e) & (K Units)
Table 65. Global Cancer Pain Sales by Application (2021-2026) & (K Units)
Table 66. Global Cancer Pain Revenue by Application (2016-2021e) & (USD Million)
Table 67. Global Cancer Pain Revenue by Application (2021-2026) & (USD Million)
Table 68. Global Cancer Pain Price by Application (2016-2021e) & (USD/Unit)
Table 69. Global Cancer Pain Price by Application (2021-2026) & (USD/Unit)
Table 70. North America Cancer Pain Sales by Country (2016-2021e) & (K Units)
Table 71. North America Cancer Pain Sales by Country (2021-2026) & (K Units)
Table 72. North America Cancer Pain Revenue by Country (2016-2021e) & (USD Million)
Table 73. North America Cancer Pain Revenue by Country (2021-2026) & (USD Million)
Table 74. North America Cancer Pain Sales by Type (2016-2021e) & (K Units)
Table 75. North America Cancer Pain Sales by Type (2021-2026) & (K Units)
Table 76. North America Cancer Pain Sales by Application (2016-2021e) & (K Units)
Table 77. North America Cancer Pain Sales by Application (2021-2026) & (K Units)
Table 78. Europe Cancer Pain Sales by Country (2016-2021e) & (K Units)
Table 79. Europe Cancer Pain Sales by Country (2021-2026) & (K Units)
Table 80. Europe Cancer Pain Revenue by Country (2016-2021e) & (USD Million)
Table 81. Europe Cancer Pain Revenue by Country (2021-2026) & (USD Million)
Table 82. Europe Cancer Pain Sales by Type (2016-2021e) & (K Units)
Table 83. Europe Cancer Pain Sales by Type (2021-2026) & (K Units)
Table 84. Europe Cancer Pain Sales by Application (2016-2021e) & (K Units)
Table 85. Europe Cancer Pain Sales by Application (2021-2026) & (K Units)
Table 86. Asia-Pacific Cancer Pain Sales by Region (2016-2021e) & (K Units)
Table 87. Asia-Pacific Cancer Pain Sales by Region (2021-2026) & (K Units)
Table 88. Asia-Pacific Cancer Pain Revenue by Region (2016-2021e) & (USD Million)
Table 89. Asia-Pacific Cancer Pain Revenue by Region (2021-2026) & (USD Million)
Table 90. Asia-Pacific Cancer Pain Sales by Type (2016-2021e) & (K Units)
Table 91. Asia-Pacific Cancer Pain Sales by Type (2021-2026) & (K Units)
Table 92. Asia-Pacific Cancer Pain Sales by Application (2016-2021e) & (K Units)
Table 93. Asia-Pacific Cancer Pain Sales by Application (2021-2026) & (K Units)
Table 94. South America Cancer Pain Sales by Country (2016-2021e) & (K Units)
Table 95. South America Cancer Pain Sales by Country (2021-2026) & (K Units)
Table 96. South America Cancer Pain Revenue by Country (2016-2021e) & (USD Million)
Table 97. South America Cancer Pain Revenue by Country (2021-2026) & (USD Million)
Table 98. South America Cancer Pain Sales by Type (2016-2021e) & (K Units)
Table 99. South America Cancer Pain Sales by Type (2021-2026) & (K Units)
Table 100. South America Cancer Pain Sales by Application (2016-2021e) & (K Units)
Table 101. South America Cancer Pain Sales by Application (2021-2026) & (K Units)
Table 102. Middle East & Africa Cancer Pain Sales by Country (2016-2021e) & (K Units)
Table 103. Middle East & Africa Cancer Pain Sales by Country (2021-2026) & (K Units)
Table 104. Middle East & Africa Cancer Pain Revenue by Country (2016-2021e) & (USD Million)
Table 105. Middle East & Africa Cancer Pain Revenue by Country (2021-2026) & (USD Million)
Table 106. Middle East & Africa Cancer Pain Sales by Type (2016-2021e) & (K Units)
Table 107. Middle East & Africa Cancer Pain Sales by Type (2021-2026) & (K Units)
Table 108. Middle East & Africa Cancer Pain Sales by Application (2016-2021e) & (K Units)
Table 109. Middle East & Africa Cancer Pain Sales by Application (2021-2026) & (K Units)
Table 110. Direct Channel Pros & Cons
Table 111. Indirect Channel Pros & Cons
Table 112. Cancer Pain Typical Distributors
Table 113. Cancer Pain Typical Customers
List of Figures
Figure 1. Cancer Pain Picture
Figure 2. Global Cancer Pain Sales Market Share by Type in 2020
Figure 3. Opioids
Figure 4. Non-Steroidal Anti-Inflammatory Drugs
Figure 5. Others
Figure 6. Global Cancer Pain Sales Market Share by Application in 2020
Figure 7. Radiotherapy
Figure 8. Chemotherapy
Figure 9. Hormone Therapy
Figure 10. Others
Figure 11. Global Cancer Pain Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Cancer Pain Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global Cancer Pain Sales (2016-2026) & (K Units)
Figure 14. Global Cancer Pain Price by Type (2016-2026) & (USD/Unit)
Figure 15. Global Cancer Pain Production Capacity (2016-2026) & (K Units)
Figure 16. Global Cancer Pain Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. Cancer Pain Market Drivers
Figure 18. Cancer Pain Market Restraints
Figure 19. Cancer Pain Market Trends
Figure 20. Global Cancer Pain Sales Market Share by Manufacturer in 2020
Figure 21. Global Cancer Pain Revenue Market Share by Manufacturer in 2020
Figure 22. Cancer Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 Cancer Pain Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 Cancer Pain Manufacturer (Revenue) Market Share in 2020
Figure 25. Global Cancer Pain Sales Market Share by Region (2016-2026)
Figure 26. Global Cancer Pain Revenue Market Share by Region (2016-2026)
Figure 27. North America Cancer Pain Revenue (2016-2026) & (USD Million)
Figure 28. Europe Cancer Pain Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific Cancer Pain Revenue (2016-2026) & (USD Million)
Figure 30. South America Cancer Pain Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa Cancer Pain Revenue (2016-2026) & (USD Million)
Figure 32. Global Cancer Pain Sales Market Share by Type (2016-2026)
Figure 33. Global Cancer Pain Revenue Market Share by Type (2016-2026)
Figure 34. Global Cancer Pain Price by Type (2016-2026) & (USD/Unit)
Figure 35. Global Cancer Pain Sales Market Share by Application (2016-2026)
Figure 36. Global Cancer Pain Revenue Market Share by Application (2016-2026)
Figure 37. Global Cancer Pain Price by Application (2016-2026) & (USD/Unit)
Figure 38. North America Cancer Pain Sales Market Share by Type (2016-2026)
Figure 39. North America Cancer Pain Sales Market Share by Application (2016-2026)
Figure 40. North America Cancer Pain Sales Market Share by Country (2016-2026)
Figure 41. North America Cancer Pain Revenue Market Share by Country (2016-2026)
Figure 42. United States Cancer Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Cancer Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Cancer Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Cancer Pain Sales Market Share by Type (2016-2026)
Figure 46. Europe Cancer Pain Sales Market Share by Application (2016-2026)
Figure 47. Europe Cancer Pain Sales Market Share by Country (2016-2026)
Figure 48. Europe Cancer Pain Revenue Market Share by Country (2016-2026)
Figure 49. Germany Cancer Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Cancer Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Cancer Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Cancer Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Cancer Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Cancer Pain Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Cancer Pain Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Cancer Pain Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Cancer Pain Revenue Market Share by Region (2016-2026)
Figure 58. China Cancer Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Cancer Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea Cancer Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Cancer Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Cancer Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Cancer Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Cancer Pain Sales Market Share by Type (2016-2026)
Figure 65. South America Cancer Pain Sales Market Share by Application (2016-2026)
Figure 66. South America Cancer Pain Sales Market Share by Country (2016-2026)
Figure 67. South America Cancer Pain Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Cancer Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Cancer Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa Cancer Pain Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Cancer Pain Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Cancer Pain Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Cancer Pain Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Cancer Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt Cancer Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Cancer Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa Cancer Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
前立腺がんの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Prostate cancer is cancer that occurs in the prostate. Scope of the Report: This report studies the Prostate Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and s…- ホルモン難治性前立腺がん（HRPCA）の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …
- 肝臓がん用薬の世界市場2018-2025 Kidney/Renal Cancer Drugs are used to cure kidney cancers.The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors boo…
- 卵巣がんの遺伝子治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- 疼痛管理の世界市場2018-2025 Pain Management could help people release pain or make them feel less painful. These drug function on phsical or mental.In 2018, the global Pain Management market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been consid…